The purpose of the VIP-A study is to determine the effect of apremilast on aortic vascular
inflammation, cardiometabolic biomarkers and body composition in patients with
moderate-severe psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Celgene Corporation National Heart, Lung, and Blood Institute (NHLBI)